Paragon Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,201
Closed -$1.76M 84
2025
Q1
$1.76M Sell
4,201
-204
-5% -$88.6K 0.67% 50
2024
Q4
$1.82M Buy
4,405
+426
+11% +$187K 0.62% 50
2024
Q3
$2.01M Buy
3,979
+18
+0.5% +$8.74K 0.65% 47
2024
Q2
$1.93M Buy
3,961
+518
+15% +$260K 0.7% 46
2024
Q1
$1.86M Buy
3,443
+1,444
+72% +$789K 0.75% 42
2023
Q4
$1.11M Buy
1,999
+46
+2% +$21.6K 0.47% 68
2023
Q3
$854K Sell
1,953
-549
-22% -$274K 0.35% 70
2023
Q2
$1.26M Sell
2,502
-211
-8% -$101K 0.41% 57
2023
Q1
$1.36M Sell
2,713
-3,528
-57% -$1.69M 0.46% 56
2022
Q4
$2.55M Sell
6,241
-3,200
-34% -$1.24M 1.12% 30
2022
Q3
$3.08M Buy
9,441
+5,167
+121% +$1.9M 1.57% 20
2022
Q2
$1.5M Buy
4,274
+853
+25% +$348K 0.75% 41
2022
Q1
$1.87M Sell
3,421
-1,538
-31% -$809K 0.78% 38
2021
Q4
$3.27M Sell
4,959
-545
-10% -$342K 1.6% 11
2021
Q3
$3.42M Buy
5,504
+229
+4% +$154K 1.66% 13
2021
Q2
$3.33M Buy
5,275
+539
+11% +$298K 1.56% 11
2021
Q1
$2.32M Buy
4,736
+1,976
+72% +$990K 1.26% 13
2020
Q4
$1.36M Buy
2,760
+432
+19% +$193K 0.73% 32
2020
Q3
$915K Sell
2,328
-114
-5% -$42.1K 0.61% 47
2020
Q2
$806K Buy
2,442
+1,372
+128% +$397K 0.65% 33
2020
Q1
$259K Buy
1,070
+80
+8% +$20.9K 0.35% 55
2019
Q4
$279K Buy
+990
New +$261K 0.3% 51

Other funds holding IDXX

Paragon Advisors's IDXX Position: Q2 2025 in Review

Paragon Advisors sold out of Idexx Laboratories (IDXX) in Q2 2025, closing a stake of 4,201 shares — an estimated $1.76M sold.

Paragon Advisors first reported a position in IDXX in Q4 2019 and held it in 22 quarters. The position peaked at $3.42M in Q3 2021. 1,234 funds tracked by Wall St. Rank hold IDXX as of Q2 2025.

  • Paragon Advisors reported no remaining Idexx Laboratories position as of Q2 2025 after selling out during the quarter.
  • Paragon Advisors sold 4,201 Idexx Laboratories shares in Q2 2025, an estimated $1.76M.
  • Paragon Advisors first reported a position in Idexx Laboratories in Q4 2019 and held it in 22 quarters.
  • Paragon Advisors's Idexx Laboratories position peaked at $3.42M in Q3 2021.
  • 1,234 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2025.

Based on Paragon Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.